• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Prevalence and characteristics of prostate cancer among participants of a community-based screening in Nigeria using serum prostate specific antigen and digital rectal examination.在尼日利亚开展的一项基于社区的筛查中,利用血清前列腺特异性抗原和直肠指检评估前列腺癌的患病率及特征
Pan Afr Med J. 2013 Aug 10;15:129. doi: 10.11604/pamj.2013.15.129.2489. eCollection 2013.
2
Percent free PSA as an additional measure in a prostate cancer screen.游离前列腺特异抗原百分比作为前列腺癌筛查的一项附加指标。
Clin Lab Sci. 2001 Spring;14(2):102-7.
3
An evaluation of usefulness of prostate specific antigen and digital rectal examination in the diagnosis of prostate cancer in an unscreened population:experience in a Nigerian teaching hospital.在未进行筛查的人群中评估前列腺特异性抗原和直肠指检在前列腺癌诊断中的效用:尼日利亚一家教学医院的经验。
West Afr J Med. 2013 Jan-Mar;32(1):8-13.
4
The digital rectal examination (DRE) remains important - outcomes from a contemporary cohort of men undergoing an initial 12-18 core prostate needle biopsy.直肠指检(DRE)仍然很重要——来自一组接受初次12 - 18针前列腺穿刺活检的男性的当代队列研究结果。
Can J Urol. 2012 Dec;19(6):6542-7.
5
Prostate-specific antigen density values among patients with symptomatic prostatic enlargement in Nigeria.尼日利亚有症状前列腺肿大患者的前列腺特异性抗原密度值
World J Surg Oncol. 2016 Jun 29;14(1):174. doi: 10.1186/s12957-016-0921-6.
6
Complexed prostate-specific antigen for early detection of prostate cancer in men with serum prostate-specific antigen levels of 2 to 4 nanograms per milliliter.复合前列腺特异性抗原用于早期检测血清前列腺特异性抗原水平为2至4纳克/毫升男性的前列腺癌。
Urology. 2002 Oct;60(4 Suppl 1):31-5. doi: 10.1016/s0090-4295(02)01693-x.
7
Incidentally Detected Adenocarcinoma Prostate in Transurethral Resection of Prostate Specimens: a Hospital Based Study from India.经尿道前列腺切除标本中偶然发现的前列腺腺癌:一项来自印度的基于医院的研究
Asian Pac J Cancer Prev. 2016;17(4):2255-8. doi: 10.7314/apjcp.2016.17.4.2255.
8
The risks of prostate cancer detection by transrectal ultrasound guide biopsy in Thai men with abnormal prostatic-specific antigen or abnormal digital rectal examination.经直肠超声引导活检在前列腺特异性抗原异常或直肠指检异常的泰国男性中检测前列腺癌的风险。
J Med Assoc Thai. 2000 Dec;83(12):1519-24.
9
Prostate specific-antigen distribution in asymptomatic Canadian men with no clinical evidence of prostate cancer.无症状且无前列腺癌临床证据的加拿大男性中前列腺特异性抗原的分布情况。
BJU Int. 2006 Jul;98(1):50-3. doi: 10.1111/j.1464-410X.2006.06193.x.
10
Early detection of high-grade prostate cancer using digital rectal examination (DRE) in men with a prostate-specific antigen level of <2.5 ng/mL and the risk of death.使用前列腺特异性抗原水平<2.5ng/mL 的男性进行数字直肠检查(DRE)早期检测高级别前列腺癌与死亡风险。
BJU Int. 2012 Dec;110(11):1636-41. doi: 10.1111/j.1464-410X.2012.11354.x. Epub 2012 Jul 3.

引用本文的文献

1
Late diagnosis among patients with prostate cancer at the Uganda Cancer Institute: a retrospective cohort study.乌干达癌症研究所前列腺癌患者的晚期诊断:一项回顾性队列研究。
Afr Health Sci. 2024 Sep;24(3):147-155. doi: 10.4314/ahs.v24i3.19.
2
Prostate cancer diagnosis and management: current practices in Africa a consultant-based survey.前列腺癌的诊断与管理:基于非洲顾问的一项调查的当前实践情况
Front Urol. 2025 Mar 17;5:1496951. doi: 10.3389/fruro.2025.1496951. eCollection 2025.
3
Quality of Care and Survival Outcomes Among Patients With Clinically Localized Prostate Cancer in Nigeria.尼日利亚临床局限性前列腺癌患者的医疗质量与生存结果
JCO Glob Oncol. 2025 Mar;11:e2400504. doi: 10.1200/GO-24-00504. Epub 2025 Mar 24.
4
Trend in incidence and clinicopathological characteristics of prostate cancer in Northern Tanzania: analysis from a population based cancer registry data 2015-2021.坦桑尼亚北部前列腺癌发病率和临床病理特征趋势:2015-2021 年基于人群癌症登记数据的分析。
BMC Cancer. 2024 Nov 19;24(1):1424. doi: 10.1186/s12885-024-13194-6.
5
Clinical characteristics and survival of patients with de novo metastatic prostate cancer treated with androgen deprivation therapy and taxane-based chemotherapy in Uganda: a retrospective study.乌干达接受雄激素剥夺疗法和紫杉烷类化疗治疗初发性转移性前列腺癌患者的临床特征和生存情况:一项回顾性研究。
BMC Cancer. 2024 Nov 14;24(1):1404. doi: 10.1186/s12885-024-13147-z.
6
Sociodemographic and clinicopathologic characteristics of patients treated with high dose rate prostate brachytherapy in Nigeria.尼日利亚接受高剂量率前列腺近距离放射治疗患者的社会人口统计学和临床病理特征。
Ecancermedicalscience. 2024 Aug 14;18:1740. doi: 10.3332/ecancer.2024.1740. eCollection 2024.
7
Epidemiology of prostate cancer in Nigeria: a mixed methods systematic review.尼日利亚前列腺癌的流行病学:一项混合方法的系统评价。
Cancer Causes Control. 2025 Jan;36(1):1-12. doi: 10.1007/s10552-024-01917-w. Epub 2024 Sep 22.
8
Pattern, Clinical Characteristics, and Impact of Family History on Prostate-Specific Antigen in Prostate Cancer: A Multicenter Study.前列腺癌中前列腺特异性抗原的家族史模式、临床特征及影响:一项多中心研究。
Am J Mens Health. 2024 Jul-Aug;18(4):15579883241264949. doi: 10.1177/15579883241264949.
9
Prostate cancer knowledge and barriers to screening among men at risk in northern Tanzania: A community-based study.坦桑尼亚北部高危男性的前列腺癌知识和筛查障碍:一项基于社区的研究。
Cancer Treat Res Commun. 2024;39:100811. doi: 10.1016/j.ctarc.2024.100811. Epub 2024 Apr 2.
10
Surgical androgen deprivation therapy in advanced prostate cancer in patients of African descent: comparison of biochemical efficacy of bilateral total and subcapsular orchidectomy.在非洲裔患者的晚期前列腺癌中进行手术去势雄激素治疗:双侧全切除术和被膜下切除术的生化疗效比较。
Afr Health Sci. 2023 Mar;23(1):483-491. doi: 10.4314/ahs.v23i1.50.

本文引用的文献

1
Prostate-cancer mortality at 11 years of follow-up.前列腺癌死亡率随访 11 年后。
N Engl J Med. 2012 Mar 15;366(11):981-90. doi: 10.1056/NEJMoa1113135.
2
Knowledge of prostate cancer screening among native African urban population in Nigeria.尼日利亚本土非洲城市人口对前列腺癌筛查的了解情况。
Nig Q J Hosp Med. 2010 Apr-Jun;20(2):94-6. doi: 10.4314/nqjhm.v20i2.58044.
3
Mortality results from the Göteborg randomised population-based prostate-cancer screening trial.哥德堡随机人群前列腺癌筛查试验的死亡率结果。
Lancet Oncol. 2010 Aug;11(8):725-32. doi: 10.1016/S1470-2045(10)70146-7. Epub 2010 Jul 2.
4
Burden of prostate cancer in southwestern Nigeria.尼日利亚西南部地区前列腺癌的负担。
Urology. 2010 Aug;76(2):412-6. doi: 10.1016/j.urology.2010.03.020. Epub 2010 May 7.
5
Prostate cancer screening in a Saudi population: an explanatory trial study.沙特人群中的前列腺癌筛查:一项解释性试验研究。
Prostate Cancer Prostatic Dis. 2010 Jun;13(2):191-4. doi: 10.1038/pcan.2009.60. Epub 2010 Jan 12.
6
The burden of prostate cancer in Canada.加拿大前列腺癌的负担。
Can Urol Assoc J. 2009 Jun;3(3 Suppl 2):S92-S100.
7
Screening and prostate-cancer mortality in a randomized European study.一项欧洲随机研究中的筛查与前列腺癌死亡率
N Engl J Med. 2009 Mar 26;360(13):1320-8. doi: 10.1056/NEJMoa0810084. Epub 2009 Mar 18.
8
Prostate cancer disparities in Black men of African descent: a comparative literature review of prostate cancer burden among Black men in the United States, Caribbean, United Kingdom, and West Africa.非洲裔美国黑人男性中的前列腺癌差异:对美国、加勒比、英国和西非的非洲裔美国黑人男性中前列腺癌负担的比较文献综述。
Infect Agent Cancer. 2009 Feb 10;4 Suppl 1(Suppl 1):S2. doi: 10.1186/1750-9378-4-S1-S2.
9
Cancer in Nigeria: a 10-year analysis of the Kano cancer registry.尼日利亚的癌症:卡诺癌症登记处的十年分析
Niger J Med. 2008 Jul-Aug;17(3):280-4. doi: 10.4314/njm.v17i3.37396.
10
Roots of prostate cancer in African-American men.非裔美国男性前列腺癌的根源。
J Natl Med Assoc. 2006 Apr;98(4):539-43.

在尼日利亚开展的一项基于社区的筛查中,利用血清前列腺特异性抗原和直肠指检评估前列腺癌的患病率及特征

Prevalence and characteristics of prostate cancer among participants of a community-based screening in Nigeria using serum prostate specific antigen and digital rectal examination.

作者信息

Ikuerowo Stephen Odunayo, Omisanjo Olufunmilade Adefolarin, Bioku Muftau Jimoh, Ajala Michael Olawale, Mordi Victor Patrick Nonyelim, Esho Julius Olusanmi

机构信息

Lagos State University College of Medicine, Ikeja, Lagos, Nigeria.

出版信息

Pan Afr Med J. 2013 Aug 10;15:129. doi: 10.11604/pamj.2013.15.129.2489. eCollection 2013.

DOI:10.11604/pamj.2013.15.129.2489
PMID:24255735
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3830465/
Abstract

INTRODUCTION

Prostate cancer (CaP) is the most commonly diagnosed cancer among Nigerian men but CaP screening is not a common practice. The true burden of the disease in Nigeria is not known. The study was aimed at studying the community burden of CaP in Lagos.

METHODS

During a community-based prostate cancer awareness program in 13 local government areas of Lagos, men aged >40 years had serum total PSA (tPSA) test and digital rectal examination (DRE). Those with abnormal DRE or tPSA >95th percentile of the cohort or both were selected for prostate biopsy (TRPB).

RESULTS

4172 men were screened and complete data was available for 4110 (98.5%). The mean age was 60.8 years. DRE was abnormal in 410 men and was significantly correlated with the age of the patient and tPSA (p<0.001). The tPSA ranged from 0 to 438.3 ng/ml with a median, mean and 95th percentile of 1.5, 2.5 and 10.0 ng/ml respectively. 341 out of the 438 (78%) men selected were subjected to TRBP. Forty-three men had histological diagnosis of CaP, giving an estimated prevalence rate of at least 1.046% or 1046 per 100,000 men of age ≥40. Only 11 (26%) had organ-confined disease while 17 (40%) had locally advanced disease and 15 (35%) men had metastatic disease. The majority of the men, 32 (74%) were reported to have Gleason's score of ≥7.

CONCLUSION

The prevalence rate of CaP among men aged ≥40 years in Lagos is higher than previously reported in hospital-based study. Majority have advanced and high-grade disease.

摘要

引言

前列腺癌(CaP)是尼日利亚男性中最常被诊断出的癌症,但前列腺癌筛查并不常见。该病在尼日利亚的实际负担尚不清楚。本研究旨在调查拉各斯地区前列腺癌的社区负担情况。

方法

在拉各斯13个地方政府辖区开展的一项基于社区的前列腺癌宣传项目中,年龄超过40岁的男性接受了血清总前列腺特异抗原(tPSA)检测和直肠指检(DRE)。那些直肠指检异常或tPSA高于该队列第95百分位数或两者皆有的男性被选作前列腺穿刺活检(TRPB)。

结果

共筛查了4172名男性,4110名(98.5%)有完整数据。平均年龄为60.8岁。410名男性直肠指检异常,且与患者年龄和tPSA显著相关(p<0.001)。tPSA范围为0至438.3 ng/ml,中位数、均值和第95百分位数分别为1.5 ng/ml、2.5 ng/ml和10.0 ng/ml。438名被选男性中有341名(78%)接受了前列腺穿刺活检。43名男性经组织学诊断为前列腺癌,估计患病率至少为1.046%,即每10万名年龄≥40岁的男性中有1046例。只有11名(26%)患有器官局限性疾病,17名(40%)患有局部晚期疾病,15名(35%)患有转移性疾病。据报告,大多数男性(32名,74%)Gleason评分≥7。

结论

拉各斯地区年龄≥40岁男性中前列腺癌的患病率高于此前基于医院研究的报告。大多数患者患有晚期和高级别疾病。